JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

B2303 Apatinib
4 Citation

Summary: VEGFR2 inhibitor, orally bioavailable, selective

≥49.4 mg/mL
B1224 Anidulafungin
1 Citation

Target: Glucan synthase

Summary: Antifungal drug

insoluble in EtOH; insoluble in H2O; ≥20.8 mg/mL
B2296 Topotecan HCl
2 Citation

Summary: Topoisomerase 1 inhibitor

≥22.9 mg/mL
B5551 Poly(I:C)
18 Citation

Target: Toll-like receptors (TLRs)

Summary: Toll-like receptor 3 (TLR3) agonist

insoluble in DMSO; insoluble in EtOH; ≥21.5 mg/mL
B6567 CNQX disodium salt

Summary: AMPA/kainate antagonist

≥27.6 mg/mL
B5455 G-1
12 Citation

Target: GPR30

Summary: GPR30 agonist, potent and selective

≥41.2 mg/mL
B5846 Radotinib(IY-5511)

Target: PDGFR|Bcr-Abl

Summary: Bcr-Abl tyrosine kinase inhibitor

≥13.73 mg/mL
A8720 MYK-461

Summary: inhibits adenosine triphosphatase activity
A8764 Rapalink-1
5 Citation

Target: mTOR

Summary: third-generation mTOR inhibitor

≥178.4 mg/mL
A8779 WM-8014

Summary: Inhibitor for KAT6A (MOZ) and KAT6B (MORF/QKF), anticancer

insoluble in H2O; insoluble in EtOH; ≥76.1 mg/mL